Viewing Study NCT06595758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-01-05 @ 5:10 PM
Study NCT ID: NCT06595758
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2024-09-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR
Sponsor: Menoufia University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Doxorobicin View
None Pharmacokinetics View
None SLC22A16 View
None CBR1 View
None SNPs View
None Toxicity View
None Neoadjuvant chemotherapy View
None Pathological complete response View
None Neutrophil to lymphocyte ratio View